home / stock / cara / cara quote
$18.91 Last:
3.05% Change Percent:
$18.47 Open:
$18.91 Previous Close:
$18.94 High:
$18.35 Low:
365,011 Volume:
03/01/2021 04:55:17 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-01 | 18.47 | 18.91 | 18.94 | 18.35 | 365,011 |
2021-02-26 | 19.69 | 18.35 | 19.9597 | 18.34 | 644,546 |
2021-02-25 | 19.33 | 19.26 | 19.91 | 18.83 | 384,402 |
2021-02-24 | 19.92 | 19.82 | 20.2 | 19.48 | 300,446 |
2021-02-23 | 19.95 | 19.69 | 20.11 | 18.67 | 526,632 |
2021-02-22 | 20 | 20.13 | 20.36 | 19.585 | 376,177 |
2021-02-19 | 19.8 | 20.03 | 20.28 | 19.38 | 367,655 |
2021-02-18 | 21.14 | 19.91 | 21.14 | 19.77 | 434,669 |
2021-02-17 | 20.51 | 21.07 | 21.9 | 20.39 | 736,927 |
2021-02-16 | 20.58 | 21.07 | 21.45 | 20.35 | 776,207 |
2021-02-15 | 19.5 | 19.88 | 20.85 | 19.1 | 784,788 |
2021-02-12 | 19.5 | 19.88 | 20.85 | 19.1 | 782,751 |
2021-02-11 | 22.5 | 19.91 | 22.6 | 19.7201 | 1,059,682 |
2021-02-10 | 21 | 21.62 | 21.9 | 20.73 | 1,190,241 |
2021-02-09 | 19.5 | 20.28 | 20.4 | 19.4 | 729,982 |
2021-02-08 | 19.2 | 19.46 | 19.52 | 18.9811 | 436,190 |
2021-02-05 | 19.38 | 19.1 | 19.525 | 18.71 | 539,743 |
2021-02-04 | 20.01 | 19.33 | 20.1155 | 19.23 | 321,338 |
2021-02-03 | 18.99 | 19.84 | 20.1599 | 18.99 | 747,065 |
2021-02-02 | 18.76 | 18.79 | 19.05 | 18.25 | 318,871 |
Cara Therapeutics Inc. Company Name:
CARA Stock Symbol:
NASDAQ Market:
Cara Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Image source: The Motley Fool. Cara Therapeutics Inc (NASDAQ: CARA) Q4 2020 Earnings Call Feb 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cara Therapeutics Inc (CARA) Q4 2020 Earnings Call Transcript
– U.S. FDA Accepts NDA Filing for KORSUVA™ Injection in CKD-aP – – Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on d...
STAMFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announ...